Shares of Carysil Ltd fell 2.34% to ₹648.80 in early trade on Tuesday following the announcement of its March quarter results. Despite reporting strong bottom-line growth, the stock declined as investors reacted to margin contraction and a nearly flat EBITDA performance.
The company reported a 19.6% year-on-year rise in net profit at ₹18.58 crore in Q4 FY25, up from ₹15.53 crore in the year-ago quarter. Revenue from operations also rose 7.2% YoY to ₹204.18 crore from ₹190.53 crore.
However, EBITDA remained almost flat at ₹34.9 crore versus ₹34.6 crore in Q4 FY24, and the EBITDA margin narrowed to 17.1% from 18.2% a year earlier, reflecting cost pressures.
For the full year ended March 2025, Carysil’s net profit rose 10.1% to ₹63.74 crore, while revenue jumped 19.3% to ₹815.57 crore.
The market response appears tempered by the lack of operating leverage in the quarter, with the profit growth not translating into improved margins.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
